COVID-19 | Healthcare Insights

  1. Home
  2.  | 
  3. Legal Insights
  4.  | Healthcare Legal Insights

President Biden’s COVID-19 Action Plan: Will Your Company Be Required to Mandate Vaccination?
9/24/2021

HHS Announces Provider Relief Fund Period 1 Reporting Grace Period and Phase 4 Distribution
9/23/2021

Top Ten Investment Trends and Opportunities in the European Healthcare Markets
9/09/2021

Investing in European Healthcare | What’s on the Horizon for 2022?
9/01/2021

New Public-Comment Period Regarding Section 301 Tariffs Impacting Certain Medical-Care and COVID-19 Response Products
8/30/2021

Mask Up, Vax Up: Illinois Governor Issues Immediate Face Covering Mandate for All, COVID-19 Vaccine Mandate for Healthcare, School and State Workers and Students
8/30/2021

OSHA Updates COVID-19 Safety Guidance for All Industries
8/18/2021

California Requires Vaccines for Most Healthcare Workers in Healthcare Facilities
8/06/2021

Five Financing Challenges in European Healthcare Private Equity in 2021 and Beyond
8/04/2021

CMS Seeks Comments on Requirements for Rural Emergency Hospitals as a New Medicare Provider Category
7/30/2021

California Requires Vaccines or Regular COVID-19 Testing for Certain Healthcare Workers and State Employees
7/29/2021

CMS Addresses Virtual Care Expansion in CY 2022 Medicare Physician Fee Schedule Proposal
7/26/2021

OSHA Maintains COVID-19 Safety Pressure on Healthcare Employers Despite Challenges from All Sides
7/14/2021

OSHA’s COVID-19 Requirements for Healthcare Employers Take Effect
6/22/2021

How to Apply the IRS’s COBRA Premium Subsidy Guidance
6/03/2021

DOJ and HHS-OIG Ramp Up COVID-Related Healthcare Fraud Enforcement Activity
6/01/2021

DEA Provides Additional Guidance Regarding Prescription and Other Policies During the COVID-19 Public Health Emergency
4/01/2020

CMS Restarts Hospital Survey Activities Delayed by Covid-19
3/31/2021

Congressional Investigations During the 117th Congress: What to Expect
3/30/2021

The next wave of covid-related criminal and civil enforcement actions is starting
3/29/2021

HHS Signals Commitment to “Predictability and Stability,” Extends Public Health Emergency Declaration “Likely” for Entirety of 2021
01/28/2021

CMS Again Limits Onsite Surveys, Citing Risks from COVID-19 Surges
01/28/2021

CMS Establishes Online Portal for Case-by-Case Section 1135 Provider Waiver Requests
01/20/2021

Waiver of State Licensure Requirements for the Delivery of COVID-19 Countermeasures via Telehealth
12/08/2020

Brexit and COVID-19: Changes to the Regulation of Medicines
10/27/2020

National Telehealth Takedown Highlights Opportunity for Providers to Enhance Compliance Efforts
10/15/2020

CMS Clarifies Emergency Preparedness Testing Exercise Requirements
10/07/2020

Healthcare Employers: What You Need to Know about the New FFCRA “Health Care Provider” Exclusion and California COVID-19 Supplemental Paid Sick Leave
09/17/2020

OCR ISSUES NEW HIPAA GUIDANCE FOR COVERED ENTITIES CONTACTING RECOVERED COVID-19 PATIENTS FOR PLASMA DONATIONS
08/28/2020

5 Key Considerations for Direct Contracting: With an Adjusted Timeline Providers May Want to Take a Second Look
06/09/2020

CMS Unveils Plans for Long Term Care Facility Infection Control Enforcement Actions
06/05/2020

HHS Announces Oversight of COVID-19 Response and Recovery Strategic Plan
06/02/2020

Heads Up, Hospitals! As COVID-19 Approaches a Steady State, Accrediting Organizations Are Going Back to Work, Too
06/02/2020

Planning Beyond the Pandemic: Considerations for Hospital and Healthcare Facility Evacuations
06/02/2020

Republicans and Democrats Introduce Competing Privacy Bills to Protect Consumers’ Health Information Related to the COVID-19 Pandemic
05/28/2020

Looking Around the Corner: Medicare Reimbursement for Telehealth Services After the Public Health Emergency
05/20/2020

COVID-19 Activities and Actions Update05/19/2020
House Approves HEROES Act
05/19/2020

Fast Track for COVID-19 Drug and Vaccine Approval in the United States and Europe
05/18/20

Reassessing Executive Compensation and Benefits in Tax-Exempt Organizations as the COVID-19 Crisis Deepens
05/15/2020

CMS Releases Second Round of COVID-19 Flexibilities
05/14/2020

CMS Announces Additional Blanket Waivers for Healthcare Facilities
05/14/2020

McDermott+Consulting: CMS Releases Second Round of COVID-19 Flexibilities
05/14/2020

Hospital at Home – CMS Expands Payments to Hospitals for Care Provided in Patient Homes
05/12/2020

Infographic | Future Forward: Data Arrangements During and After COVID-19
05/11/2020

CMS Announces Immediate COVID-19 Reporting Requirements Applicable to Long Term Care Facilities
Updated 05/11/2020

COVID-19: Financial Relief Opportunities for Healthcare Providers
Updated: 05/06/2020

But Wait, There’s More! CMS Provides Additional Regulatory Relief Through Expanded Blanket Waivers
05/05/2020

Top Takeaways: Critical Business Considerations for Life Sciences and Medical Device Companies During COVID-19
05/05/2020

COVID-19 Telehealth: Where Things Stand on May 5, 2020
05/05/2020

HHS Distributes $22B to Hotspots and Rural Providers
04/04/2020

CMS Issues FAQs on EMTALA Requirements for Hospitals
05/03/2020

CFIUS Developments: National Security Reviews of Foreign Investments in the United States
05/01/2020

CMS Updates COVID-19 Guidance for MA Organizations and Part D Sponsors, Addresses Telehealth Visit Risk Adjustment
05/01/2020

CMS Issues Explanatory Guidance on Nationwide Blanket Stark Law Waivers
04/30/2020

Bill Extends Medicare Telehealth Coverage for Therapy Providers
04/29/2020

CMS Continues to Refine Survey and Infection Control Guidance for Long-Term Care Facilities During the COVID-19 Pandemic
04/28/2020

HHS Announces Additional Distributions from Emergency Fund
04/25/2020

Congress Supplements the Paycheck Protection Program and Emergency Fund
04/23/2020

CMS Provides Flexibility for Independent Freestanding Emergency Departments to Enroll in Medicare as Hospitals During the COVID-19 Pandemic
04/23/2020

Board Financial Oversight Responsibilities During Pandemic-Driven Distress
04/23/2020

TEXAS GOVERNOR REDUCES RESTRICTIONS ON SURGICAL AND MEDICAL PROCEDURES – Updated
04/22/2020

$800M IN STABILIZATION FUNDS FOR MASSACHUSETTS MEDICAID PROVIDERS – Updated
04/22/2020

FDA ISSUES ENFORCEMENT POLICY FOR DIGITAL HEALTH THERAPEUTIC DEVICES FOR PSYCHIATRIC DISORDERS DURING COVID-19
04/21/2020

REVISITING EXECUTIVE AND BOARD SUCCESSION PLANNING IN RESPONSE TO THE PANDEMIC
04/21/2020

CMS ENHANCES COVID-19 REPORTING AND SURVEILLANCE OBLIGATIONS FOR LONG TERM CARE FACILITIES
04/21/2020

Florida’s Extension of its COVID-19 Out-of-State Provider Waiver: A Sign of the Times
04/17/2020

ASSURING APPROPRIATE INFORMATION FLOW TO THE RISK AND COMPLIANCE COMMITTEES
04/16/2020

COVID-19 RELIEF LAW INCLUDES MAJOR CHANGES TO SUBSTANCE USE DISORDER CONFIDENTIALITY LAW
04/15/2020

INFOGRAPHIC: DIGITAL HEALTH AND COVID-19: ROADMAP TO SUCCESSFUL IMPLEMENTATION
04/14/2020

$200 Million of Funding for COVID-19 Telehealth Program
04/14/2020

ACTION STEP CONSIDERATIONS FOR LIFE SCIENCES COMPANIES AMIDST THE COVID-19 PANDEMIC
04/13/2020

COVID-19 CONSIDERATIONS: HOSPITALS & HEALTH SYSTEMS Resource Guide
04/13/2020

HHS Distributes $30B to FFS Medicare Providers
04/11/2020

Friday Newsflash: Public Health and Social Services Emergency Fund
04/10/2020

FLEXIBILITIES FOR DMEPOS, LABORATORIES AND AMBULANCES DURING COVID-19
04/10/2020

MEDICARE RESOURCES AND INFORMATION FOR HOME HEALTH AND HOSPICE AGENCIES DURING THE COVID-19 PANDEMIC
04/10/2020

EMERGENCY STATE ACTION AFFECTING BOARD PROCESSES AND CORPORATE FILINGS
04/10/2020

AVOIDING CONFUSION OVER STATE LICENSING LAWS AS CMS FURTHER LOOSENS TELEMEDICINE RESTRICTIONS
04/10/2020

CARES ACT REFORMS TO ADDRESS DRUG AND DEVICE SHORTAGES AND UPDATES TO THE OTC DRUG MONOGRAPHS
04/09/2020

FDA UPDATE: ENFORCEMENT POLICIES FOR GOWNS, GLOVES, STERILIZERS, DISINFECTANT DEVICES AND AIR PURIFIERS
04/09/2020

FDA ISSUES ENFORCEMENT POLICIES FOR FACE MASKS AND RESPIRATORS; EMERGENCY USE AUTHORIZATION FOR VENTILATORS
04/09/2020

VIRTUAL BOARD MEETINGS IN TIMES OF CRISIS
04/07/2020

UPDATED: CMS ISSUES NATIONWIDE BLANKET WAIVERS OF STARK LAW AND OIG ISSUES AN AKS POLICY STATEMENT
04/01/2020

UPDATED: CMS EXPANDS ACCELERATED AND ADVANCE PAYMENT PROGRAM TO ALL MEDICARE PROVIDERS, SUPPLIERS
03/30/2020

FLEXIBILITIES FOR RURAL HEALTH CENTERS, FEDERALLY QUALIFIED HEALTH CENTERS DURING COVID-19
04/06/2020

CMS ACCELERATED AND ADVANCE PAYMENTS TIMELINE
04/05/2020

CMS EXPANDS FLEXIBILITIES IN RESPONSE TO COVID-19
04/05/2020

EXEMPTIONS AND CONSIDERATIONS FOR THE TREATMENT OF OPIOID USE DISORDER DURING THE COVID-19 EMERGENCY
04/05/2020

CMS PROVIDES GUIDANCE TO AMBULATORY SURGICAL CENTERS TEMPORARILY ENROLLING IN MEDICARE AS HOSPITALS DURING THE COVID-19 PANDEMIC
04/05/2020

THE EXECUTIVE COMMITTEE IN TIMES OF CRISIS
04/03/2020

CARES ACT MID-SIZED LOAN PROGRAM OVERVIEW
04/03/2020

OCR WAIVES PENALTIES FOR CERTAIN PHI USE, DISCLOSURE BY BUSINESS ASSOCIATES DURING COVID-19 EMERGENCY
04/03/2020

COVID-19 TELEHEALTH: WHERE THINGS STAND ON APRIL 2, 2020
04/02/2020

ACTION STEP CONSIDERATIONS FOR LIFE SCIENCES COMPANIES AMIDST THE COVID-19 PANDEMIC
04/02/2020

CMS ISSUES NATIONWIDE BLANKET WAIVERS OF STARK LAW
04/01/2020

DEA PROVIDES ADDITIONAL GUIDANCE REGARDING PRESCRIPTION AND OTHER POLICIES DURING THE COVID-19 PUBLIC HEALTH EMERGENCY
04/01/2020

CMS ISSUES BROAD PACKAGE OF BLANKET WAIVERS UNDER SECTION 1135
03/31/2020

CMS UPDATES COVID-19 INFECTION CONTROL GUIDANCE FOR INPATIENT HOSPITAL SETTINGS
03/31/2020

CMS UPDATES INFECTION CONTROL GUIDANCE WITH FOCUS ON DIALYSIS FACILITIES
03/31/2020

CMS ISSUES COVID-19 INFECTION CONTROL GUIDANCE FOR CERTAIN OUTPATIENT SETTINGS
03/31/2020

CMS ISSUES ADDITIONAL GUIDANCE ON EMTALA REQUIREMENTS FOR HOSPITALS
03/31/2020

CMS ISSUES COVID-19 INFECTION CONTROL GUIDANCE FOR INTERMEDIATE CARE FACILITIES AND PSYCHIATRIC RESIDENTIAL TREATMENT FACILITIES
03/31/2020

HHS OCR ISSUES GUIDANCE REMINDING HEALTHCARE PROVIDERS TO AVOID DISCRIMINATION IN MAKING CARE DECISIONS
03/31/2020

CMS EXPANDS ACCELERATED AND ADVANCE PAYMENT PROGRAM TO ALL MEDICARE PROVIDERS, SUPPLIERS
03/30/2020

CORPORATE AUTHORITY FOR EXTRAORDINARY DELIVERY OF CARE DECISIONS
03/30/2020

FDA ISSUES FAQS ON 3D PRINTING OF MEDICAL DEVICES, ACCESSORIES, COMPONENTS AND PARTS DURING THE COVID-19 PANDEMIC
03/29/2020

CMS ANNOUNCES REGULATORY FLEXIBILITY FOR CLIA LABORATORIES
03/29/2020

PRECAUTIONS FOR HEALTHCARE PROVIDERS SOURCING PERSONAL PROTECTIVE EQUIPMENT FROM FOREIGN SUPPLIER
03/29/2020

FDA OPENS SUBMISSIONS FOR COVID-19 IND APPLICATIONS
03/27/2020

CARES ACT OFFERS RELIEF, SUPPORT FOR US HEALTHCARE SECTOR DURING COVID-19 RESPONSE
03/26/2020

SECRETARY AZAR CALLS ON GOVERNORS TO MODIFY REGULATIONS TO EXPAND HEALTHCARE WORKFORCE
03/26/2020

HHS OIG ESTABLISHES PORTAL AND PROCESS TO PROVIDE GUIDANCE ON ANTI-KICKBACK AND BENEFICIARY INDUCEMENT STATUTES DURING COVID-19 CRISIS
03/26/2020

OCR ISSUES GUIDANCE REGARDING COVID-19, HIPAA, AND DISCLOSURES TO FIRST RESPONDERS AND PUBLIC HEALTH AUTHORITIES
03/25/2020

HEALTHCARE BOARDCOVID-19 OVERSIGHT CHECKLIST
03/25/2020

OIG CLARIFIES SCOPE OF TELEHEALTH COPAYMENT WAIVER
03/25/2020

KEY COVID-19 DEVELOPMENTS AND GUIDANCE FOR AMBULATORY SURGERY CENTERS
03/25/2020

FDA SEEKS TO IMPROVE VENTILATOR ACCESS, RELAXES REMS REQUIREMENTS DURING COVID-19
03/24/2020

FDA OFFERS GUIDANCE ON CLINICAL TRIALS DURING COVID-19 PANDEMIC
03/23/2020

CMS DRAMATICALLY MODIFIES AND EXPEDITES THE MEDICARE ENROLLMENT PROCESS TO COMBAT COVID-19
03/23/2020

OCR ENFORCEMENT WAIVERS OF CERTAIN HIPAA REQUIREMENTS IN FURTHERANCE OF TELEHEALTH DURING COVID-19 PANDEMIC
03/23/2020

HOW TO HANDLE ELECTIVE SURGERIES AND PROCEDURES DURING THE COVID-19 PANDEMIC
03/22/2020

FDA UPDATE: FDA ENFORCEMENT POLICY, NON-INVASIVE REMOTE MONITORING DEVICES
03/22/2020

EXECUTIVE AND PHYSICIAN COMPENSATION, BENEFITS AND CONTRACT ISSUES IN THE COVID-19 ERA
03/22/2020

HOW TO ADDRESS BENEFICIARY INDUCEMENT QUESTIONS DURING COVID-19
03/20/2020

COVID-19 TELEHEALTH GUIDANCE: WHAT YOU NEED TO KNOW
03/19/2020

CMS GUIDANCE AND WAIVERS FOR MA AND PART D PLANS’ RESPONSE TO COVID-19
03/18/2020

DEA: IN-PERSON VISIT NOT REQUIRED FOR CONTROLLED SUBSTANCES PRESCRIPTION DURING PUBLIC HEALTH EMERGENCY
03/18/2020

FDA OFFERS LABORATORIES, MANUFACTURERS NEW FLEXIBILITY TO EXPEDITE COVID-19 TESTING
03/17/2020

SECTION 1135 WAIVERS NOW AVAILABLE, BUT SOME WAIVERS MAY REQUIRE APPROVAL
03/17/2020

CMS RELEASES FACT SHEETS ON COVID-19 MEDICARE COVERAGE, BILLING GUIDELINES</a >03/17/2020

THE FAMILIES FIRST CORONAVIRUS RESPONSE ACT: WHAT YOU NEED TO KNOW
03/16/2020

THE FAMILIES FIRST CORONAVIRUS RESPONSE ACT: WHAT YOU NEED TO KNOW
03/16/20

SECURITIES LAW: COVID-19 RISK FACTOR DISCLOSURES IN ASC OFFERINGS
03/13/2020

CMS RELEASES UPDATED GUIDANCE ON EMTALA REQUIREMENTS AND COVID-19 IMPLICATIONS
03/13/2020

CMS COVID-19 INFECTION CONTROL GUIDANCE FOR NURSING, HOSPICE, HOME HEALTH AND DIALYSIS FACILITIES
03/13/2020

FDA UPDATE: COVID-19 TESTING, VACCINE DEVELOPMENT AND OTHER IMPACTS
03/12/2020

CALIFORNIA’S COVID-19 EMERGENCY MAY PERMIT HEALTHCARE SERVICES BY OUT-OF-STATE PRACTITIONERS
03/06/2020

BIPARTISAN BILL RELAXES FEDERAL TELEHEALTH REQUIREMENTS IN THE WAKE OF COVID-19
03/05/2020

CMS TAKES UNPRECEDENTED ACTION TO MODIFY SURVEY ACTIVITIES IN RESPONSE TO COVID-19
03/05/2020

THIS IS NOT A DRILL: HOSPITAL AND HEALTH SYSTEM PREPAREDNESS FOR COVID-19
03/02/2020

PRIVACY, HIPAA, SECURITY AND GDPR – COVID-19 CONSIDERATIONSJAPANESE VERSION (HIPAA)
03/2020

×

×

×

XING


Related Site:     McDermott+ Consulting

Attorney Advertising ©2020 McDermott Will & Emery